HU CFAR Requests for Proposals

When is the next HU CFAR RFP?

For the current RFP, applications are due on December 2nd, 2016 for awards beginning February 1st, 2017.  An additional RFP will be released in the spring of 2017 for a potential funding start date of August 1, 2017.  Going forward, the new RFP schedule will allow for funding with an earliest possible start date of August 1st and January 1st of each year.

How do I apply for HU CFAR funding?

Download the application and follow the instructions in the HU CFAR Request for Proposals.

What type of award can I apply for?

The Developmental Award provides both salary and research support for promising early-career investigators who are transitioning to independent funding.  Applications will be judged on the basis of the merit of the scientific proposal. 

Who is eligible to apply for HU CFAR funding?

Eligibility for Developmental Awards:  The Developmental Award is intended to support junior investigators who are on a career path leading to an independent research program.  This is recognized as an extended transition, and applications will be considered from candidates beginning at the time of their transition from a training grant or similar support to mentored independent research (K level) funding to the point at which they have received NIH R01 or similar level funding.

Applicants may be at the post-doctoral fellow, research fellow, instructor, research associate, research scientist, or assistant professor level at any Harvard University School (e.g., HMS, HSPH, FAS) or one of its affiliated institutions, including (but not limited to) BIDMC, BWH, CHB, DFCI, Fenway Health, IDI, MGH and Lemuel Shattuck.  Investigators at the rank of associate professor or above (including senior research scientists and principal research scientists at HSPH) will be judged too senior for consideration.

If you are an NIH T32 award recipient at the time of the award date, or later receive a T32 award during the award cycle, you are ineligible to receive HU CFAR funding per federal restrictions; however, if you are a current T32 awardee, you may submit an application in response to this RFP as long as you can accept funding within six months of the earliest possible start date of this RFP.

If you are a current recipient of an NIH K award, you are required to submit with your CFAR application NIH sponsor approval indicating that you are eligible to receive CFAR funding.  Investigators are not eligible for salary support on a CFAR Developmental award if they are on a mentored K award.  

Applications from senior investigators will not be considered for funding.  Senior investigators are defined as already having received NIH R01 funding as the principal investigator or funding at a similar level.  This does not include R21, R34, or RO3 funding or subcontract funding through the R01 mechanism.

For eligibility of clinical research projects: Projects Involving Clinical Research or Clinical Trials” (e.g., observational studies, sub-studies using existing data from an ongoing clinical trial) may be funded by the CFAR.  However, clinical trials that involve testing of biomedical or behavioral interventions, particularly those that involve more than minimal risk, may not be eligible for CFAR funding

How much can I apply for?

Developmental Award Funding – Direct Costs:
You may request up to $60,000 in salary and/or non-salary costs for one year.  In addition, you may also request your institutional fringe rate on salary, calculated on top of the $60,000 direct cost total.  

 Developmental Award Funding – Indirect (Overhead) Costs:
The HU CFAR will award indirect costs at the rate of 25 percent for the domestic portion of the budget.  The HU CFAR will award indirect costs at the rate of 8 percent for the international portion of the budget, if any.  Please note that proposals are frequently recommended to be supported with Harvard University institutional support, in which case indirect costs will not be awarded.

What are the review criteria?

The Committee will review the applications based on the following criteria:

  • Overall scientific merit, level of innovation, and relevance of the proposal to AIDS research. 
  • Specific and narrowly focused application with realistic goals.
  • Potential for generating independent funding.
  • Potential for drawing investigators from other fields into AIDS research.
  • Collaborative proposals that extend the scope of current CFAR activities across multiple participating Harvard laboratories/institutions are highly encouraged. Collaborative proposals will be evaluated on the scientific merits of each individual component of the project, as well as the overall integration of the projects.
cfar_rfp-february_2017_final_9_30_16.pdf150 KB